Abstract
Objective
Compare the incidence of hypoglycemia in neonates born to patients with diabetes, based on last maternal glucose before delivery.
Study design
Cohort of singleton births from individuals with pregestational and gestational diabetes (GDM) from 2017 to 2019.
Results
We included 853 deliveries. Maternal hyperglycemia before delivery was associated with 1.8-fold greater risk of neonatal hypoglycemia (glucose < 45 mg/dL) in patients with GDM on medication (adjusted risk ratio (aRR): 1.8; 95% CI: 1.1–2.7), compared with euglycemia. This association was not seen in diet-controlled GDM (0.5; 0.23–1.1), nor in Type 1 (1.1; 0.88–1.4), or Type 2 pregestational diabetes (1.1; 0.61–1.9). Further, pregestational diabetes, compared to GDM, regardless of intrapartum maternal glucose control, was associated with neonatal hypoglycemia and NICU admission.
Conclusion
Maternal hyperglycemia before delivery only carried a higher risk of neonatal hypoglycemia in those with GDM on medications. Other interventions to reduce neonatal hypoglycemia are needed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
ACOG practice bulletin no. 201: pregestational diabetes mellitus. Obstet Gynecol. 2018;132:E228-E248. https://doi.org/10.1097/AOG.0000000000002960.
Committee on Practice B-O. ACOG practice bulletin no. 190: gestational diabetes mellitus. Obs Gynecol. 2018;131:e49–e64. https://doi.org/10.1097/AOG.0000000000002501.
Dodd JM, Crowther CA, Antoniou G, Baghurst P, Robinson JS. Screening for gestational diabetes: the effect of varying blood glucose definitions in the prediction of adverse maternal and infant health outcomes. Aust N. Zeal J Obstet Gynaecol. 2007;47:307–12. https://doi.org/10.1111/j.1479-828X.2007.00743.x.
Metzger BE, Contreras M, Sacks DA, Watson W, Dooley SL, Foderaro M, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002. https://doi.org/10.1056/nejmoa0707943.
Pettitt DJ, Knowler WC, Baird HR, Bennett PH. Gestational diabetes: Infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care. 1980;3:458–64. https://doi.org/10.2337/diacare.3.3.458.
Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles M-A, Pettitt DJ. Childhood obesity and metabolic imprinting the ongoing effects of maternal hyperglycemia. Diabetes Care. 2007;30:2287–92. https://doi.org/10.2337/dc06-2361
Ryan EA, Al-Agha R. Glucose control during labor and delivery. Curr Diab Rep. 2014;14. https://doi.org/10.1007/s11892-013-0450-4.
Yamamoto JM, Benham J, Mohammad K, Donovan LE, Wood S. Systematic review or meta-analysis Intrapartum glycaemic control and neonatal hypoglycaemia in pregnancies complicated by diabetes: a systematic review. Diabet Med. 2018;35:173–83. https://doi.org/10.1111/dme.13546.
Carron Brown S, Kyne-Grzebalski D, Mwangi B, Taylor R. Effect of management policy upon 120 Type 1 diabetic pregnancies: Policy decisions in practice. Diabet Med. 1999;16:573–8. https://doi.org/10.1046/j.1464-5491.1999.00124.x.
Kline GA, Edwards A. Antepartum and intra-partum insulin management of type 1 and type 2 diabetic women: Impact on clinically significant neonatal hypoglycemia. Diabetes Res Clin Pr. 2007;77:223–30. https://doi.org/10.1016/j.diabres.2006.10.024.
Dude A, Niznik CM, Szmuilowicz ED, Peaceman AM, Yee LM. Management of diabetes in the intrapartum and postpartum patient. Am J Perinatol. 2018;35:1119–26. https://doi.org/10.1055/s-0038-1629903.
Dude AM, Niznik C, Peaceman AM, Yee LM. Evaluation of an intrapartum insulin regimen for women with diabetes. Obstet Gynecol. 2020;136:411–6. https://doi.org/10.1097/AOG.0000000000003940.
Hamel MS, Kanno LM, Has P, Beninati MJ, Rouse DJ, Werner EF. Intrapartum glucose management in women with gestational diabetes mellitus: a randomized controlled trial. Obstet Gynecol. 2019;133:1171–7. https://doi.org/10.1097/AOG.0000000000003257.
Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361:1339–48. https://doi.org/10.1056/NEJMoa0902430.
Yamamoto JM, Donovan LE, Mohammad K, Wood SL. Research: pregnancy severe neonatal hypoglycaemia and intrapartum glycaemic control in pregnancies complicated by type 1, type 2 and gestational diabetes. Diabet Med. 2020;37:138–46. https://doi.org/10.1111/dme.14137.
Blumer I, Hadar E, Hadden DR, Jovanovic L, Mestman JH, Murad MH, et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metabol. 2013;98:4227–4249. https://doi.org/10.1210/jc.2013-2465.
Adamkin DH. Neonatal hypoglycemia. Curr Opin Pediatr. 2016;28:150–5. https://doi.org/10.1097/MOP.0000000000000319.
Harris DL, Weston PJ, Harding JE. Incidence of Neonatal Hypoglycemia in Babies Identified as at Risk. J Pediatr. 2012;161:787–91. https://doi.org/10.1016/j.jpeds.2012.05.022.
Acknowledgements
AYC received salary support from the grant K12HD000849, awarded to the Reproductive Scientist Development Program by the Eunice Kennedy Shriver National Institute of Child Health & Human Development and Burroughs Wellcome Fund. AMM received salary support from the Charles Koch Foundation. The Charles Koch Foundation was not involved in the research or preparation of this manuscript. This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award UL 1TR002541) and financial contributions from Harvard University and its affiliated academic healthcare centers. These findings were presented at the Society for Maternal Fetal Medicine 40th Annual Conference 2020 in Grapevine, Texas, February 3, 2020 to February 8, 2020.
Author information
Authors and Affiliations
Contributions
TZA was involved in conceptualization, methodology, investigation, and writing of the original draft. RA was involved in investigation, review of writing, and editing of writing. AM was involved in validation, formal analysis, review of writing, and editing of writing. AYC was involved in conceptualization, methodology, investigation, review of writing, editing of writing, and supervision. All authors approved the final version to be published and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Anwer, T.Z., Aguayo, R., Modest, A.M. et al. Reexamining intrapartum glucose control in patients with diabetes and risk of neonatal hypoglycemia. J Perinatol 41, 2754–2760 (2021). https://doi.org/10.1038/s41372-021-01292-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-021-01292-3
This article is cited by
-
Intrapartum maternal glycaemic control for the prevention of neonatal hypoglycaemia: a systematic review and meta-analysis
BMC Pregnancy and Childbirth (2024)